Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Evaluating factors predicting survival in patients of NSCLC with poor performanc...
Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India
5 Aug 2021
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
26 Jul 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
19 Jul 2021
COVID-19 and cancer: Highlights from ASCO 2021
Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
22 Jun 2021
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or ...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
14 Jun 2021
Real world evidence on the use of antibody drug conjugates in peripheral T-cell ...
Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Leba...
14 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
11 Jun 2021
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in t...
Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA
11 Jun 2021
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy...
Prof Heather Wakelee - Stanford University, Stanford, USA
11 Jun 2021
Clinically sufficient vitamin D levels at breast cancer diagnosis and survival o...
Prof Song Yao - Roswell Park Comprehensive Cancer Center, Buffalo, USA
10 Jun 2021
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax fo...
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey/RWJBarnabas Health, N...
10 Jun 2021
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC
Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA
9 Jun 2021
